Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1Terminated 1Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Rectal Neoplasms 1Radiation Injuries 1Prostatic Neoplasms 1Polycystic Ovary Syndrome 1Pancreatic Neoplasms 1Motor Activity 1Melanoma 1Malnutrition 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Insulin Resistance 1Head and Neck Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Body Weight 1

Interventions

Exercise 10Standard of Care 2Resistance Training 2High-Intensity Interval Training 2secukinumab 1methyl hydroxyethyl cellulose 1Walking 1Metformin 1Focus Groups 1Exercise Therapy 1Educational Status 1Diet Therapy 1Control Groups 1Cognitive Training 1Caloric Restriction 1Andrographis paniculata extract 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Motor Activity × Diet Therapy × Clear all
NCT01482286 2022-03-15

PULSE

Pennington Biomedical Research Center

Phase 3 Terminated
32 enrolled 10 charts

Body Weight, Insulin Resistance, Motor Activity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡